Posted in Commercial Senju launches first-in-class dry eye disease drug in Japan April 10, 2026 Pharmaphorum Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market. CommercialOphthalmologyRead full story